The Tavis Smiley Show

Financial Literacy Group Host the First Annual Debt Free Conference in Los Angeles on June 24, 2023

Retrieved on: 
Tuesday, June 13, 2023

SANTA MONICA, Calif., June 13, 2023 /PRNewswire-PRWeb/ -- Many companies, homeowners and debtors have already made an RSVP and the event is expected to sell out. Booths are available to business owners and there are still a few left, the networking is expected to be intense. Ron Harris, the CEO of Financial Literacy Group and his partner, David Weiner will be the keynote speakers at the event. The venue in Culver City can comfortably accommodate upwards of 450 persons.

Key Points: 
  • Financial Literacy Group, plans and hosts the First Annual Debt Free Conference in Los Angeles at the Courtyard Marriott, 6333 Bristol Parkway, CA 90230 Culver City on June 24, 2023 at 11:am to 2:pm, followed by a business mixer from 3:pm to 8:pm Pacific Time.
  • Booths are available to business owners and there are still a few left, the networking is expected to be intense.
  • Ron Harris, the CEO of Financial Literacy Group and his partner, David Weiner will be the keynote speakers at the event.
  • Financial Literacy Group is changing the narrative on financial wellness, our solutions equalize the financial playing field between middle class Americans and financial institutions.

FOUNDATION FOR SARCOIDOSIS RESEARCH LAUNCHES ITS FIRST-EVER CLINICAL TRIAL EQUITY INITIATIVE FOR BLACK AND AFRICAN AMERICANS

Retrieved on: 
Thursday, September 15, 2022

CHICAGO, Sept. 15, 2022 /PRNewswire/ -- The Foundation for Sarcoidosis Research (FSR) is proud to announce the launch of the Ignore No More: ACTe Now! (Advance Clinical Trials for Equity in Sarcoidosis) campaign. The goals of this campaign are to increase representation of Black American sarcoidosis patients in clinical trials, raise awareness of disparities that exist in sarcoidosis, identify the challenges and barriers that contribute to lower participation by Black Americans in clinical trials, and to provide recommendations that foster a more inclusive approach to recruiting patients for clinical trials and research.  

Key Points: 
  • Black Americans are 2.5 times more likely to have sarcoidosis and are 12 times more likely to die from sarcoidosis than White Americans.
  • While Black Americans are disproportionately impacted by chronic illnesses and diseases across the spectrum, they are significantly underrepresented in clinical trials and research.
  • "It is imperative to increase representation of Black Americans in clinical trials and research efforts in order to close the gap in care and improve patient outcomes for Black Americans with sarcoidosis," said Mary McGowan, Chief Executive Officer for FSR.
  • The Foundation for Sarcoidosis Research (FSR) is the leading international organization dedicated to finding a cure for sarcoidosis and to improving care for sarcoidosis patients through research, education, and support.